Targeting key pathways in tumour growth and development
2005
Targeting Key Pathways in Tumor Growth and Development
publication
Author Information
Author(s): Herbst R S
Primary Institution: The University of Texas MD Anderson Cancer Center
Conclusion
Molecular-targeted therapies have shown promise in treating tumors by inhibiting specific growth factors.
Supporting Evidence
- New anticancer agents are being developed that target specific pathways in tumor progression.
- Agents like ZD6474, which inhibit VEGF and EGF, have shown promise in clinical studies.
Takeaway
Scientists are finding new ways to fight cancer by targeting specific parts of the tumor's growth process, which can help make treatments better.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website